This inventor holds 5 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignee: Cytori Therapeutics, Inc.. Active years: 2009-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- San Diego, CA (US) (2009 - 2014)
- Rancho Santa Fe, CA (US) (2009 - 2018)
Company Filing History:
Years Active: 2009-2018
Title: Michael J Schulzki: Innovator in Regenerative Medicine
Introduction
Michael J Schulzki is a prominent inventor based in Rancho Santa Fe, California. He has made significant contributions to the field of regenerative medicine, holding a total of five patents. His work focuses on the isolation and application of adipose-derived regenerative cells, which have the potential to revolutionize medical treatments.
Latest Patents
Among his latest patents, Schulzki has developed systems for isolating and using clinically safe adipose-derived regenerative cells. These systems and methods are designed to separate cells from a variety of tissues, particularly adipose tissue. The automated systems provide rapid and reliable methods for separating and concentrating regenerative cells, such as stem and progenitor cells, suitable for re-infusion into subjects.
Career Highlights
Schulzki is currently associated with Cytori Therapeutics, Inc., where he continues to advance his research and innovations in regenerative medicine. His work has garnered attention for its potential applications in various medical fields, including tissue repair and regeneration.
Collaborations
Some of his notable coworkers include Marc H Hedrick and John K Fraser, who have collaborated with him on various projects related to regenerative medicine.
Conclusion
Michael J Schulzki's contributions to the field of regenerative medicine through his innovative patents and collaborations highlight his role as a key figure in advancing medical technology. His work continues to pave the way for new treatments and therapies that can improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
